Multivariate regression showed that CD166 and KRAS exon 2 mutation statuses do not have any correlation to the clinical histopathological factors of the patients which include age, sex, tumor stage, lymph node status, distant metastasis and overall survival. The gene discussed is ALCAM; the disease is neoplasm.